Best mortgage deals of the week

As possibility of multiple interest rate cuts dwindle here's what banks and building societies are offering

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

4.5800

-0.0300

(-0.65%)

At close: 04:00PM EDT

4.6100

+0.03

(+0.66%)

After hours:

07:13PM EDT

Currency in USD

Earnings estimate	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
No. of analysts	11	11	11	10
Avg. Estimate	-0.21	-0.16	-0.62	-0.34
Low estimate	-0.28	-0.32	-0.84	-0.76
High estimate	-0.14	-0.06	-0.26	-0.11
Year ago EPS	-0.28	-0.4	-1.18	-0.62

Revenue estimate	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
No. of analysts	10	10	11	10
Avg. Estimate	86.01M	98.36M	395.92M	475.7M
Low estimate	83.53M	96M	382.08M	398M
High estimate	87.56M	101.53M	406.75M	510.06M
Year ago sales	68.78M	82.49M	331.41M	395.92M
Sales growth (year/est)	25.10%	19.20%	19.50%	20.20%

Earnings history	30/03/2023	29/06/2023	29/09/2023	30/12/2023
Est. EPS	-0.3	-0.23	-0.23	-0.24
Actual EPS	-0.28	-0.4	-0.19	-0.31
Difference	0.02	-0.17	0.04	-0.07
Surprise %	6.70%	-73.90%	17.40%	-29.20%

EPS trend	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
Current estimate	-0.21	-0.16	-0.62	-0.34
7 days ago	-0.21	-0.16	-0.61	-0.34
30 days ago	-0.21	-0.16	-0.61	-0.34
60 days ago	-0.22	-0.16	-0.72	-0.39
90 days ago	-0.22	-0.16	-0.72	-0.39

EPS revisions	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
Up last 7 days	N/A	N/A	N/A	N/A
Up last 30 days	1	1	1	1
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	N/A	1	N/A

Growth estimates	BCRX	Industry	Sector(s)	S&P 500
Current qtr.	25.00%	N/A	N/A	N/A
Next qtr.	60.00%	N/A	N/A	N/A
Current year	47.50%	N/A	N/A	N/A
Next year	45.20%	N/A	N/A	N/A
Next 5 years (per annum)	44.80%	N/A	N/A	N/A
Past 5 years (per annum)	N/A	N/A	N/A	N/A